Thammasat-NECTEC-Chula's Thai Language and Cognition Assessment (TLCA) is a cognitive paper-based test consisting of 21 tasks that cover 3 domains: memory, language, and other cognitive abilities. The TLCA follows some aspects of the existing tests (Thai Addenbrooke's Cognitive Examination-Revised (Thai-ACE-R) and the Thai Montreal Cognitive Assessment Test (Thai-MoCA)) and many parts were reconstructed to be more adapted to the Thai culture. Data obtained from the test will be able to precisely distinguish between patients with Mild Cognitive Impairment (MCI), Alzheimer's Disease (AD), and Normal healthy Controls (NC). The TLCA was tested on 90 participants (32 on the paper-based version and 58 on the computerized version) using a scoring procedure and speech features from verbal responses with machine learning classification. The scoring results showed significant difference between non-AD (NC + MCI) vs AD participants in 3 domains and could differentiate between NC and MCI, while machine classification could classify in three settings: NC vs non-NC (MCI + AD), AD vs non-AD and NC vs MCI vs AD. These promising results suggest that TLCA could be further verified and used as an efficient assessment in MCI and AD screening for Thais.Clinical relevance- The speech feature analysis of TLCA showed promising result for screening MCI and AD for Thais.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/EMBC46164.2021.9630779 | DOI Listing |
BMJ Health Care Inform
January 2025
Biomedical Informatics and Clinical Epidemiology Department, Chiang Mai University Faculty of Medicine, Chiang Mai, Thailand.
Background: Low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol (non-HDL-C) levels are paramount in atherosclerotic cardiovascular disease risk management. However, 94.4% of Thai young adult are unaware of their condition.
View Article and Find Full Text PDFJ Headache Pain
January 2025
Chulalongkorn Headache and Orofacial Pain (CHOP) Service and Research Group, Chulalongkorn University, Bangkok, Thailand.
Nat Med
January 2025
Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Am J Public Health
January 2025
Teeraboon Lertwanichwattana and Ram Rangsin are with Phramongkutklao College of Medicine, Bangkok, Thailand. Supattra Srivanichakorn, Sairat Noknoy, and Sirinapa Siriporn Na Ratchaseema are with the Royal College of Family Physicians of Thailand, Bangkok. Nittaya Phanuphak is with the Institute of HIV Research and Innovation, Bangkok. Kitti Wongthavarawat is with the National Science and Technology Development Agency, Bangkok. Arunotai Siriussawakul, Varalak Srinonprasert, and Pattara Leelahavarong are with the Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok. Parawee Chevaisrakul and Putthapoom Lumjiaktase are with the Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok. Aree Kumpitak is with the Thai Network of People Living With HIV, Bangkok. Nopphan Phromsri is with the Human Settlement Foundation, Bangkok. Yupadee Sirisinsuk is with the Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok. Pongtorn Kietdumrongwong is with the Bangkok Dusit Medical Services, Bangkok. Apinun Aramrattana is with the Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
To determine the overall mortality and risk factors of COVID-19 patients who were admitted to the Home Isolation (HI) program in Bangkok, Thailand, during the epidemic crisis in 2021. We conducted a retrospective cohort study using the data from a government telehealth application from July to December 2021. The vital status was verified from the government database on September 20, 2022.
View Article and Find Full Text PDFPLoS One
January 2025
Department of Radiation Oncology, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand.
Radiotherapy is the main treatment for patients with head and neck cancer (HNC) and is associated with an increased risk of ischemic cerebrovascular events (ICVE). The purpose of this cross-sectional study was to determine the incidence of ICVE and carotid artery stenosis (CAS) in patients with HNC who receive radiotherapy and the risk factors for CAS. We enrolled 907 patients with HNC who underwent radiotherapy between February 2011 and June 2022 and obtained information on their clinical and tumor characteristics and their treatment from the clinical records.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!